Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Caohuandan Pharmaceutical is a Chinese pharmaceutical enterprise primarily focused on the development and manufacturing of Traditional Chinese Medicine (TCM) and health-related products. Established in 1998 and headquartered in Meihekou, Jilin Province, the company operates modern GMP-certified production lines for various dosage forms, including capsules, tablets, and granules. Its product portfolio emphasizes traditional formulas for cardiovascular health, kidney function, and general vitality, often marketed under the flagship "Caohuandan" brand. The company leverages the rich natural resources of the Changbai Mountain region for its herbal sourcing and raw materials. Jilin Caohuandan Pharmaceutical integrates traditional herbal knowledge with modern pharmaceutical technology to serve the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Caohuandan Pharmaceutical.